Home » Topics » BioWorld Science

BioWorld Science
RSS

Oral rhLF reduces the effects of allergen challenge in a sheep model of asthma

June 4, 2004

Bone Care International highlights third quarter progress

June 4, 2004

Caspase-3 inhibitor improves islet graft functions

June 4, 2004

New COX-2 inhibitors prepared and tested by Korean team

June 3, 2004

Merck KGaA patent covers new factor Xa and factor VIIa inhibitors

June 3, 2004

Novel macrocyclic lactam with antimicrobial and antitumor activity

June 3, 2004

Dual D2/5-HT1A ligands with potential in schizophrenia therapy

June 3, 2004

Myriad Genetics presents new NK1 antagonists for emesis, pain, etc.

June 3, 2004

Aventis claims hormone-sensitive lipase inhibitors and their use as antidiabetic agents

June 3, 2004

cPLA2alpha is a novel therapeutic target for asthma therapy

June 3, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...